[HTML][HTML] Targeting PI3K/AKT/mTOR signaling pathway in breast cancer

H Li, L Prever, E Hirsch, F Gulluni - Cancers, 2021 - mdpi.com
Simple Summary PI3K signaling pathway plays an essential role in many cellular processes
and is frequently altered in breast cancer, leading to increased tumor growth and reduced …

Oncogenic roles of the PI3K/AKT/mTOR axis

M Aoki, T Fujishita - Viruses, genes, and cancer, 2017 - Springer
Abstract The PI3K/AKT/mTOR pathway is frequently activated in various human cancers and
has been considered a promising therapeutic target. Many of the positive regulators of the …

Drugging an undruggable pocket on KRAS

D Kessler, M Gmachl, A Mantoulidis, LJ Martin… - Proceedings of the …, 2019 - pnas.org
The 3 human RAS genes, KRAS, NRAS, and HRAS, encode 4 different RAS proteins which
belong to the protein family of small GTPases that function as binary molecular switches …

PI3K and cancer: lessons, challenges and opportunities

DA Fruman, C Rommel - Nature reviews Drug discovery, 2014 - nature.com
The central role of phosphoinositide 3-kinase (PI3K) activation in tumour cell biology has
prompted a sizeable effort to target PI3K and/or downstream kinases such as AKT and …

The upstream pathway of mTOR-mediated autophagy in liver diseases

H Wang, Y Liu, D Wang, Y Xu, R Dong, Y Yang, Q Lv… - Cells, 2019 - mdpi.com
Autophagy, originally found in liver experiments, is a cellular process that degrades
damaged organelle or protein aggregation. This process frees cells from various stress …

mTOR kinase structure, mechanism and regulation

H Yang, DG Rudge, JD Koos, B Vaidialingam, HJ Yang… - Nature, 2013 - nature.com
The mammalian target of rapamycin (mTOR), a phosphoinositide 3-kinase-related protein
kinase, controls cell growth in response to nutrients and growth factors and is frequently …

Structural basis for regulation of phosphoinositide kinases and their involvement in human disease

JE Burke - Molecular cell, 2018 - cell.com
Lipid phosphoinositides play fundamental roles in virtually all pathways that control a cell's
decision to grow, move, divide, and die. Because of this, kinases that phosphorylate …

PI3K signalling: the path to discovery and understanding

B Vanhaesebroeck, L Stephens… - Nature reviews Molecular …, 2012 - nature.com
Over the past two decades, our understanding of phospoinositide 3-kinases (PI3Ks) has
progressed from the identification of an enzymatic activity associated with growth factors …

Dual or multi-targeting inhibitors: The next generation anticancer agents

NM Raghavendra, D **ili, S Kadasi, A Mettu… - European journal of …, 2018 - Elsevier
Dual-targeting/Multi-targeting of oncoproteins by a single drug molecule represents an
efficient, logical and alternative approach to drug combinations. An increasing interest in this …

RAS interaction with PI3K: more than just another effector pathway

E Castellano, J Downward - Genes & cancer, 2011 - journals.sagepub.com
RAS proteins are small GTPases known for their involvement in oncogenesis: around 25%
of human tumors present mutations in a member of this family. RAS operates in a complex …